PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsHyperlipoproteinemias
MeSH D006951 - hyperlipoproteinemias
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006949:Hyperlipidemias
0 Companies
0 Drugs
Success rate
D006951: 
Hyperlipoproteinemias
D006938:Hyperlipoproteinemia type ii
$
Success rate
D006952:Hyperlipoproteinemia type iii
0 Companies
0 Drugs
Success rate
D006953:Hyperlipoproteinemia type iv
0 Companies
0 Drugs
Success rate
D006954:Hyperlipoproteinemia type v
0 Companies
0 Drugs
Success rate
D008072:Hyperlipoproteinemia type i
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AbbVieFenofibrate Tricor  1993-12-31 $606 M Q3/12-Q3/13 
Accord HealthcareAtorvastatin Atorvastatin  2018-03-30   
Pravastatin Pravastatin  2016-11-17   
Rosuvastatin Rosuvastatin  2016-10-31   
Simvastatin Simvastatin  2008-02-26   
AgnitioAtorvastatin Atorvastatin  2021-09-02   
Ajanta PharmaFenofibrate Fenofibrate  2018-07-23   
Alembic PharmaceuticalsFenofibrate Fenofibrate  2019-08-09   
Alkem LaboratoriesAtorvastatin Atorvastatin  2018-12-21   
Colesevelam Colesevelam  2018-10-05   
Ezetimibe, Simvastatin Ezetimibe Simvastatin  2017-12-22   
Rosuvastatin Rosuvastatin  2017-03-21   
AllerganClofibrate Clofibrate  1987-09-18   
Colesevelam Colesevelam  2020-09-02   
Ezetimibe, Simvastatin Ezetimibe Simvastatin  2017-04-26   
Lovastatin Lovastatin  2001-12-17   
Pravastatin Pravastatin  2006-10-23   
Rosuvastatin Rosuvastatin  2016-04-29   
Simvastatin Simvastatin  2006-12-20   
Althera PharmaceuticalEzetimibe, Rosuvastatin Roszet 2033-05-01 2021-03-23   
Amneal PharmaceuticalsEzetimibe, Simvastatin Ezetimibe Simvastatin  2017-11-21   
Fenofibrate Fenofibrate  2018-03-19   
Rosuvastatin Rosuvastatin  2018-10-16   
Pitavastatin Pitavastatin  2024-08-20   
ANI PharmaceuticalsEzetimibe, Simvastatin Ezetimibe Simvastatin  2017-04-26   
Fenofibrate Fenofibrate  2018-04-30   
Colestipol Colestipol  2023-03-10   
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
50%
1/2
Phase 3
86%
19/22
Approved: 16Overall Success rate: 43%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use